Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel anticancer agents disclosed in recent patents

July 8, 2008

pSivida commences BrachySil phase IIb pancreatic cancer trial

July 8, 2008

Initial phase II ASI-1411 findings show promise in acute myeloid leukemia

July 8, 2008

Recent patents claim novel anticancer agents

July 7, 2008

OncoGenex to independently develop lead cancer drug OGX-011

July 4, 2008

XL-228 well tolerated in drug-resistant Philadelphia chromosome-positive leukemias

July 4, 2008

Recent patents cover novel anticancer agents

July 4, 2008

SuperGen comments on results from phase III trial comparing Dacogen to BSC in MDS

July 4, 2008

CHMP requests additional data analyses from phase III INT-0133 trial of IDM's mifamurtide

July 4, 2008

Preliminary response rate data reported for discontinued phase III trial of CoFactor

July 3, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...